Souhaitez-vous accéder aux communiqués récents ?

NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Fiverr International Ltd. (NYSE: FVRR), the company that is transforming the way the world creates and works together, today announced that Micha Kaufman,...

WATERTOWN, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of...

A Media Snippet accompanying this announcement is available by clicking on this link. LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Sports.com Studios Ltd, the original content division of SEGG...

CLEVELAND, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Kanopy announced today that it is signing on as a producer and distributor of Charlie Kaufman’s new short film “How to Shoot a Ghost” in advance of its...

Fiverr Releases Its 2024 Impact Report

WATERTOWN, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives...

– Completed Phase 3 enrollment for DURAVYU™ in wet AMD with over 800 patients enrolled and randomized – – LUGANO and LUCIA trials each rapidly enrolled in seven months underscoring strong physician...

WATERTOWN, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives...

Strong Q2 results: We delivered solid execution across Marketplace and Services segments, together with continued operational discipline. Marketplace revenue was led by strong growth across AI-related...

– LUCIA pivotal Phase 3 trial enrolled and randomized over 400 patients in seven months, demonstrating continued strong enthusiasm for the DURAVYU pivotal program across the global retinal community –...